Clopitab Cv Gold 20mg Capsule belongs to the therapeutic classification of Anticoagulants and Antiplatelet Agents, Antihyperlipidemic Agents / Statin drugs. The primary composition for this medicine is Aspirin 75 MG, Atorvastatin 20 MG, Clopidogrel 75 MG.

Let your doctor know if are sensitive to atorvastatin, clopidogrel or aspirin, have any Active liver disease, Active bleeding issues (like peptic ulcer, brain haemorrhage), pregnant or planning to become pregnant or breastfeeding. The patient should inform the doctor that they are taking Clopitab-CV Gold 20 Capsule 10's before any surgery is scheduled or any new medicine is taken. Atorvastatin present in Clopitab-CV Gold 20 Capsule 10's is a pregnancy category X drug so it is contraindicated in pregnant women. As it may cause harm to the fetus if administered to pregnant women. The risk of muscle disease might increase if Clopitab-CV Gold 20 Capsule 10's is taken with an antibiotic (Clarinathromycin), anti-HIV drugs (ritonavir, lopinavir, darunavir, atazanavir, indinavir) and antifungal (itraconazole). Coadministration with anticoagulant like warfarin may cause gastric bleeding and other bleeding problems. So, if you are using any blood-thinning agents let your doctor know about this. Clopitab-CV Gold 20 Capsule 10's contains Atorvastatin which can cause muscle problems like myopathy and rhabdomyolysis. Patients with Active liver disease should use Clopitab-CV Gold 20 Capsule 10's with caution. The safety and effectiveness of Clopitab-CV Gold 20 Capsule 10's have not been established, so its use should be avoided in pediatric patients or children less than 12 years of age. Discontinuation of Clopitab-CV Gold 20 Capsule 10's may lead to the occurrence of cardiovascular events like heart attack, stroke and angina (heart-related chest pain). Hence, you should consult a doctor before stopping the dose of Clopitab-CV Gold 20 Capsule 10's.